API SUPPLIERS

API Suppliers

0

US DMFs Filed

0

CEP/COS Certifications

0

JDMFs Filed

0

EU WC

0

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

API Market Place

0

INTERMEDIATES

0

DOSSIERS // FDF

USA (Orange Book)

0

Europe

0

Canada

0

Australia

0

South Africa

0

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

FDF Market Place

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

5

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Also known as: 1702816-75-8, Pi3kdelta-in-2, Pi3k(delta)-in-2, 05hyk3cv9n, Yy-20394, Pi3k

Molecular Formula

C₂₈H₃₇FN₆O₅S

Molecular Weight

588.7 g/mol

InChI Key

NVWKNQGHVMMAJW-UHFFFAOYSA-N

FDA UNII

05HYK3CV9N

Linperlisib is an orally available selective inhibitor of the delta form of phosphatidylinositol 3-kinase (PI3-kinase subunit delta; PI3K-delta; PI3Kdelta), with potential antineoplastic activity. Upon oral administration linperlisib selectively binds to and inhibits PI3K-delta and prevents the activation of the PI3K/AKT signaling pathway. This decreases proliferation of and induces cell death in PI3K-delta over-expressing tumor cells. PI3K-delta also plays a key role in the B-cell receptor (BCR) signaling pathway and the proliferation of certain hematologic cancer cells. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells, thereby minimizing serious side effects.

1 2D Structure

Linperlisib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide

2.1.2 InChI

InChI=1S/C28H37FN6O5S/c1-28(2,36)20-5-7-34(8-6-20)17-19-13-21(29)15-22-24(31-27(32-25(19)22)35-9-11-40-12-10-35)18-14-23(33-41(4,37)38)26(39-3)30-16-18/h13-16,20,33,36H,5-12,17H2,1-4H3

2.1.3 InChI Key

NVWKNQGHVMMAJW-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)(C1CCN(CC1)CC2=C3C(=CC(=C2)F)C(=NC(=N3)N4CCOCC4)C5=CC(=C(N=C5)OC)NS(=O)(=O)C)O

2.2 Other Identifiers

2.2.1 UNII

05HYK3CV9N

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 1702816-75-8

2. Pi3kdelta-in-2

3. Pi3k(delta)-in-2

4. 05hyk3cv9n

5. Yy-20394

6. Pi3k

7. A-in-2

8. N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide

9. Methanesulfonamide, N-(5-(6-fluoro-8-((4-(1-hydroxy-1-methylethyl)-1-piperidinyl)methyl)-2-(4-morpholinyl)-4-quinazolinyl)-2-methoxy-3-pyridinyl)-

10. N-(5-(6-fluoro-8-((4-(2-hydroxypropan-2-yl) Piperidin-1-yl)methyl)-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-)methanesulfonamide

11. Linperlisib [inn]

12. Pi3kd-in-2

13. Pi3ko-in-2

14. Unii-05hyk3cv9n

15. Pi3k.delta.-in-2

16. Linperlisib [who-dd]

17. Pi3k -in-2

18. Chembl4574601

19. Schembl18032489

20. Gtpl10466

21. Us9656996, Compound 10

22. Bdbm309960

23. Bcp20830

24. Ctc81675

25. Ex-a1436

26. Pi3k(c)(1/2)-in-2

27. Cs-6973

28. Yy20394

29. Compound 10 [us20160244432]

30. Yy-20394; Pi3k

31. A-in-2

32. Ac-35638

33. Hy-102031

34. N-[5-[6-fluoro-8-[[4-(1-hydroxy-1-methylethyl)-1-piperidinyl]methyl]-2-(4-morpholinyl)-4-quinazolinyl]-2-methoxy-3-pyridinyl]-methanesulfonamide

2.4 Create Date

2015-05-04

3 Chemical and Physical Properties

Molecular Formula	C₂₈H₃₇FN₆O₅S
Molecular Weight	588.7 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	12
Rotatable Bond Count	8
Exact Mass	588.25301764 g/mol
Monoisotopic Mass	588.25301764 g/mol
Topological Polar Surface Area	138 Å²
Heavy Atom Count	41
Formal Charge	0
Complexity	958
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1